Online citations, reference lists, and bibliographies.
← Back to Search

The Relationship Of Age To Outcome In Myasthenia Gravis

D. Donaldson, M. Ansher, S. Horan, R. Rutherford, S. Ringel
Published 1990 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This study, a retrospective review of 165 patients with myasthenia gravis, compares the course of the disease for patients with onset before 50 and at or after 50. There were no significant differences between age groups for presenting symptoms, but more of the older patients had progressed to severe disease. More of the younger than the older patients were in remission or were asymptomatic on medication at the last visit. Sixty-two percent of those treated with steroids developed complications, with a larger portion of these being in the older group. Cataracts, infection, and bone changes were particularly significant for the older population. Complications of azathioprine treatment and plasmapheresis were less common. Thymoma was more common in the older population; these patients did no worse than the population as a whole. Sixty-five percent of our patients have undergone thymectomy, most by a modified transsternal approach. A much larger portion of those who underwent thymectomy were in remission at the last visit than those who did not.
This paper references
10.1111/J.1749-6632.1987.TB51398.X
Clinical Characteristics of Myasthenia Gravis with Other Autoimmune Diseases
Y. Monden (1987)
10.1111/j.1749-6632.1987.tb51320.x
The Course of Myasthenia Gravis in Patients Treated with Corticosteroids, Azathioprine, and Plasmapheresis a
F. Cornelio (1987)
10.1111/j.1749-6632.1987.tb51317.x
The Course of Myasthenia Gravis and Therapies Affecting Outcome a
D. Grob (1987)
10.1136/jnnp.43.7.644
Controversies about the treatment of myasthenia gravis.
L. Rowland (1980)
10.1111/J.1749-6632.1987.TB51328.X
Thymectomy as Primary Therapy in Myasthenia Gravis
C. W. Olanow (1987)
10.1111/j.1749-6632.1987.tb51327.x
Immunosuppressive Drugs: Azathioprine in the Treatment of Myasthenia Gravis
G. Matell (1987)
10.1056/NEJM197401102900204
Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment.
M. Seybold (1974)
10.1111/J.1749-6632.1987.TB51318.X
Clinical Experience in More Than 2000 Patients with Myasthenia Gravis
G. Genkins (1987)
10.1097/00000658-198208000-00001
A Prospective Study of Thymectomy and Serum Acetylcholine Receptor Antibodies in Myasthenia Gravis
C. W. Olanow (1982)
10.1111/j.1749-6632.1987.tb51325.x
Long‐Term Corticosteroid Treatment of Myasthenia Gravis
T. R. Johns (1987)
10.1056/NEJM197711242972102
Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
P. Dau (1977)
The outcome of thymectomy in nonthymomatous myasthenia gravis.
M. H. Huang (1988)
10.1097/00005792-197809000-00002
MYASTHENIA GRAVIS IN PATIENTS WITH THYMOMA, WITH PARTICULAR REFERENCE TO ONSET AFTER THYMECTOMY
N. Brunner (1978)
Projection of the population of the US. by age, sex and race: 1983-2080. Current population reports series p-25 #952
Census Bureau Of (1984)
10.1212/WNL.26.8.729
Long‐term administration of corticosteroids in myasthenia gravis
J. Mann (1976)
10.1001/ARCHNEUR.1982.00510140016004
Thymectomy in late-onset myasthenia gravis.
C. Olanow (1982)
10.1111/j.1600-0404.1988.tb06970.x
Ocular myasthenia: diagnostic and therapeutic problems
A. Evoli (1988)
10.1001/ARCHNEUR.1981.00510080040003
Plasmapheresis in refractory generalized myasthenia gravis.
P. Kornfeld (1981)
10.1016/S0022-5223(19)41326-3
High-dose steroids for perioperative management of patients with myasthenia gravis undergoing thymectomy. A preliminary report.
H. Bolooki (1978)
Projection of the population of the US. by age, sex and race: 1983-2080. Current population reports series
Bureau of Census (1984)
Thymectomy in patients more than forty years of age with myasthenia gravis.
G. Slater (1978)
Plasmapheresis in myasthenia gravis.
R. Miller (1981)
10.1001/ARCHNEUR.1985.04060110031011
High-dose intravenous methylprednisolone in myasthenia gravis.
E. Arsura (1985)
10.1001/ARCHNEUR.1982.00510180028007
Complications of plasma exchange in neurological patients.
R. Rodnitzky (1982)
Thymectomy for myasthenia aravis: a changing perspective
JC Heiser (1982)
10.1212/WNL.38.2.258
Azathioprine toxicity during long‐term immunosuppression of generalized myasthenia gravis
R. Hohlfeld (1988)
10.1001/ARCHNEUR.1986.00520020049018
Immunosuppressive drug therapy in myasthenia gravis.
E. Niakan (1986)
10.1111/j.1749-6632.1987.tb51322.x
The Electrodiagnosis of Myasthenia Gravis
D. Sanders (1987)



This paper is referenced by
10.1002/mus.21555
Ocular myasthenia gravis in a senior population: Diagnosis, therapy, and prognosis
J. A. Allen (2010)
10.1590/S0004-282X1999000300018
Miastenia grave: avaliação clínica de 153 pacientes
F. M. Cunha (1999)
10.1111/j.1468-1331.2010.03017.x
Course and prognosis of myasthenia gravis: a systematic review
Z.-F. Mao (2010)
10.1007/S11940-002-0037-X
Thymectomy for myasthenia gravis
G. Gronseth (2002)
10.1007/s00415-019-09222-2
Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis
S. Kim (2019)
10.1590/S0004-282X2010000600003
Myasthenia gravis in Ceará, Brazil: clinical and epidemiological aspects.
Aline de Almeida Xavier Aguiar (2010)
Myasthenia gravis from Thomas Willis to the present.
A. Afifi (2005)
10.1080/08916930500050491
Suppression by mAbs against DQB1 peptides of in vitro proliferation of AChR-specific T cells from myasthenia gravis patients
M. Oshima (2005)
10.1016/S1072-7515(01)00795-5
Analysis of thymectomy for myasthenia gravis in older patients: a 20-year single institution experience.
P. Abt (2001)
10.3341/kjo.2011.25.1.1
Comparison of Clinical Manifestations between Patients with Ocular Myasthenia Gravis and Generalized Myasthenia Gravis
H. Roh (2011)
10.1080/01616412.2018.1525121
Clinical differences of early and late-onset myasthenia gravis in 985 patients
Lingling Fan (2018)
10.1212/WNL.41.4.520
Diagnosis of thymoma in myasthenies using anti‐striated muscle antibodies
Douglas J. Lanska, MD, MS (1991)
10.1002/mus.21191
Racial differences in myasthenia gravis in Alabama
S. Oh (2009)
10.1212/WNL.42.10.1888
The epidemiology of myasthenia gravis in central and western Virginia
L. H. Phillips (1992)
10.1002/mus.24054
Effects of balance strategy training in myasthenia gravis: A case study series
S. Wong (2014)
10.1590/S0004-282X1991000400007
Miastenia grave tratamento clínico x cirúrgico
L. C. Werneck (1991)
10.18999/NAGJMS.55.1-4.103
Remission of myasthenia gravis: clinical, electrophysiological and immunological studies.
K. Mano (1993)
10.1002/mus.23964
Late‐onset myasthenia gravis: A review when incidence in older adults keeps increasing
Nuha M. Alkhawajah (2013)
10.1016/j.regg.2012.02.003
[Is myasthenia gravis overlooked in the over-80s? Two case reports].
Francisco Javier Castellote Varona (2012)
10.7759/cureus.6808
Myasthenia Gravis with Elderly Onset at Advanced Age
Otto Jesus Hernandez Fustes (2020)
10.1111/j.1468-1331.2007.02038.x
Clinical and laboratory‐reconfirmed myasthenia gravis: a population‐based study
M. Ööpik (2008)
10.1111/ggi.13296
Combined operation for thymoma with myasthenia gravis and coronary artery disease in an octogenarian
H. Hino (2018)
10.1212/WNL.0b013e3181a41211
Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals
A. Alshekhlee (2009)
10.1002/mus.20030
Clinical evaluation and management of myasthenia gravis
J. Keesey (2004)
Late Onset Myasthenia Gravis Masquerading As Stroke
A. Leventoğlu (2009)
AN UNUSUAL PRESENTATION OF MYASTHENIA GRAVIS
N. Anuradha (2015)
10.1212/WNL.48.Suppl_5.70S
Intensive care of the myasthenic patient
S. Mayer (1997)
10.1001/ARCHNEUR.56.1.25
Late-onset myasthenia gravis: a changing scene.
J. Aarli (1999)
10.1007/978-3-319-73585-6_6
Clinical Presentations of Myasthenia Gravis
J. B. M. Kuks (2018)
Dystonia , tremor , and parkinsonism in a 54 year old man with 2-hydroxyglutaric aciduria
G. Sorrentino (2004)
10.1136/jnnp.64.1.78
Mortality and survival in myasthenia gravis: a Danish population based study
P. Christensen (1998)
10.1007/978-1-4757-5548-0_71
Critical Care of Myasthenic Crisis
N. Janjua (2003)
See more
Semantic Scholar Logo Some data provided by SemanticScholar